Literature DB >> 25701781

Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.

Hao Wu1, Meihua Jin2, Donghe Han3, Mingsheng Zhou4, Xifan Mei5, Youfei Guan6, Chang Liu7.   

Abstract

This study aimed to investigate the mechanism by which aerobic swimming training prevents high-fat-diet-induced nonalcoholic fatty liver disease (NAFLD). Forty-two male C57BL/6 mice were randomized into normal-diet sedentary (ND; n = 8), ND exercised (n = 8), high-fat diet sedentary (HFD; n = 13), and HFD exercised groups (n = 13). After 2 weeks of training adaptation, the mice were subjected to an aerobic swimming protocol (60 min/day) 5 days/week for 10 weeks. The HFD group exhibited significantly higher mRNA levels of fatty acid transport-, lipogenesis-, and β-oxidation-associated gene expressions than the ND group. PANDER and FOXO1 expressions increased, whereas AKT expression decreased in the HFD group. The aerobic swimming program with the HFD reversed the effects of the HFD on the expressions of thrombospondin-1 receptor, liver fatty acid-binding protein, long-chain fatty-acid elongase-6, Fas cell surface death receptor, and stearoyl-coenzyme A desaturase-1, as well as PANDER, FOXO1, and AKT. In the HFD exercised group, PPARα and AOX expressions were much higher. Our findings suggest that aerobic swimming training can prevent NAFLD via the regulation of fatty acid transport-, lipogenesis-, and β-oxidation-associated genes. In addition, the benefits from aerobic swimming training were achieved partly through the PANDER-AKT-FOXO1 pathway.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise; FOXO1; Fatty acid transport; Fatty acid β-oxidation; Lipogenesis; PPARα

Mesh:

Substances:

Year:  2015        PMID: 25701781     DOI: 10.1016/j.bbrc.2015.02.046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.

Authors:  Huifeng Pi; Mengyu Liu; Yu Xi; Mengyan Chen; Li Tian; Jia Xie; Mingliang Chen; Zhen Wang; Min Yang; Zhengping Yu; Zhou Zhou; Feng Gao
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

Review 2.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

Review 3.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

4.  Maternal exercise modifies body composition and energy substrates handling in male offspring fed a high-fat/high-sucrose diet.

Authors:  Charline Quiclet; Hervé Dubouchaud; Phanélie Berthon; Hervé Sanchez; Guillaume Vial; Farida Siti; Eric Fontaine; Cécile Batandier; Karine Couturier
Journal:  J Physiol       Date:  2017-10-25       Impact factor: 5.182

5.  Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.

Authors:  Nadine Gehrke; Jana Biedenbach; Yvonne Huber; Beate K Straub; Peter R Galle; Perikles Simon; Jörn M Schattenberg
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

6.  Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice.

Authors:  Jinchunzi Yang; Neira Sáinz; Elisa Félix-Soriano; Eva Gil-Iturbe; Rosa Castilla-Madrigal; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

7.  Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training.

Authors:  Chaheyla R St Aubin; Amy L Fisher; Jose A Hernandez; Tom L Broderick; Layla Al-Nakkash
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-23       Impact factor: 3.249

8.  Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway.

Authors:  Wei Chen; Xiaowei Wang; L I Huang; B O Liu
Journal:  Exp Ther Med       Date:  2015-11-17       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.